Trials / Completed
CompletedNCT05458635
Predictors of Pulmonary Hypertension in Patients With Hypersensitivity Pneumonitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 29 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Hypersensitivity pneumonitis (HP) is a complex immune mediated disorders caused by repeated inhalation of and sensitization to wide range of antigens including organic particles and chemical compounds, leading to exaggerated immuneresponse. Hypersenstivity pneumonitis is a common form of diffuse parenchymal lung diseases in Egypt .Pulmonary hypertension has been found as a complication of a number of diseases affecting the lung interstitium, including hypersensitivity pneumonitis, with subsequent affection of the life expectancy Rationale of the study: to find predictors for the development of pulmonary hypertension in patients with hypersensitivity pneumonitis
Detailed description
Cross sectional study included 60 patients with established diagnosis of HP , work up includes history of exposure, clinical examination, HRCT chest, ABGs,6MWD, desaturation degree , spirometry, echocardiography and right heart catheter in patients with high echo probability of PH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Right heart catheter | Right heart catheterization was performed for 4 cases with high probability of pulmonary hypertension using multi-lumen swan ganz catheter. |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2020-10-31
- Completion
- 2021-03-15
- First posted
- 2022-07-14
- Last updated
- 2022-07-14
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05458635. Inclusion in this directory is not an endorsement.